Skip to main content

Table 3 AVP concentrations in plasma, CSF and saliva by GOS outcome groups

From: Sex-specific issues of central and peripheral arginine-vasopressin concentrations in neurocritical care patients

GOS

No. of patients

AVP Plasma

AVP CSF

AVP Saliva

(median [IQR])

(median [IQR])

(median [IQR])

1

2

2.61 [2.45, 2.77]

2.35 [2.15, 2.55]

1.48 [1.37, 1.58]

2

9

3.10 [2.49, 4.11]

3.18 [2.99, 4.39]

1.67 [1.35, 2.90]

3

16

2.38 [2.10, 3.12]

3.42 [2.76, 3.92]

1.52 [1.04, 1.98]

4 + 5

3

3.12 [2.43, 3.35]

2.93 [2.70, 3.04]

1.88 [1.82, 2.15]

p

 

0.618

0.319

0.500

  1. GOS Glasgow Outcome Score
Back to article page

BMC Neuroscience

ISSN: 1471-2202

Contact us